Our mission is to Accelerate the Cure for Type 1 Diabetes by directly funding cure-based diabetes researcher Dr. James Shapiro and his team at the University of Alberta.
The Diabetes Research Institute Foundation Canada (DRIFCan) was established in 2005 to fundraise for diabetes research, specifically for the Edmonton Protocol. The protocol is named for the islet transplantation group at the University of Alberta in the Canadian city of Edmonton, where the protocol was first devised in the late 1990s, and published in The New England Journal of Medicine in July 2000. Dr. James Shapiro is the Director of the Clinical Islet Cell Transplant Program at the University of Alberta, where there are several ongoing human clinical trials.The Clinical Islet Transplant Program has performed more than 600 transplants to date, more than any other islet transplant center in the world.
What People Are Saying
"There is always room for improvement and we need to work hard in the lab and continue to make progress. Our team's goal is to drive research today to accelerate a cure for tomorrow."
— Dr. James Shapiro